valencefund.com
See Our Portfolio
http://www.valencefund.com/portfolio
Dr Dani P. Bolognesi, Ph.D. Robert R. Bonczek, J.D. Peter R. Dolan. Dr Henry A. McKinnell, Ph.D. A public cardiovascular and inflammatory disease company. A public company focused on targeted cancer therapeutics. A public company focused on optimizing the combination of proven cancer therapies. A private company developing the hormone, Relaxin, in acute heart failure - acquired by Novartis, originally Corthera. Invuity's products enable less invasive surgery using proprietary photonic solutions. Celator ...
investor.anthera.com
Analyst Coverage - Anthera
http://investor.anthera.com/analysts.cfm
Phone: 1.510.856.5600. Anthera is covered by the following analysts. Yigal D. Nochomovitz. HC Wainwright and Co. Piper Jaffray and Co. Please note that any opinions, estimates or forecasts regarding Anthera's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Anthera or its management. Anthera does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
investor.anthera.com
Stock Information - Anthera
http://investor.anthera.com/stockquote.cfm
Phone: 1.510.856.5600. 002 ( 0.678%). 4:00 PM ET on Aug 26, 2016. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Anthera does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. Adjusted historic prices for the week of August 22, 2016. Aug 22, 2016. Aug 23, 2016.
investor.anthera.com
- Anthera
http://investor.anthera.com/eventdetail.cfm?EventID=156973
Phone: 1.510.856.5600. Details on this event are not available. Anthera Pharmaceuticals, Inc. 25801 Industrial Blvd, Suite B. Hayward, CA 94545.
investor.anthera.com
Historic Stock Lookup - Anthera
http://investor.anthera.com/stocklookup.cfm
Phone: 1.510.856.5600. Adjusted historic prices for the week of August 22, 2016. Aug 22, 2016. Aug 23, 2016. Aug 24, 2016. Aug 25, 2016. Aug 26, 2016. Year End Stock Prices. Anthera Pharmaceuticals, Inc. 25801 Industrial Blvd, Suite B. Hayward, CA 94545.
investor.anthera.com
Press Releases - Anthera
http://investor.anthera.com/releases.cfm
Phone: 1.510.856.5600. Aug 16, 2016. Anthera Pharmaceuticals Announces Appointment of Dr. William Shanahan Jr. as Chief Medical Officer. File is in Briefcase. Aug 16, 2016. Anthera Pharmaceuticals Announces Positive DSMB Review in Phase 3 SOLUTION Study of Sollpura™. File is in Briefcase. Aug 9, 2016. Anthera Pharmaceuticals Provides Business Update and Reports 2016 Second Quarter Financial Results. Met enrollment target in SOLUTION study and enrolled first patient in SIMPLICITY study of Sollpura™S...
investor.anthera.com
Investor Relations - Anthera
http://investor.anthera.com/index.cfm
Phone: 1.510.856.5600. We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. 4:00 PM ET on Aug 19, 2016. Delayed at least 20 minutes. Aug 16, 2016. Anthera Pharmaceuticals Announces Appointment of Dr. William Shanahan Jr. as Chief Medical Officer. Aug 16, 2016. Anthera Pharmaceuticals Announces Positive DSMB Review in Phase 3 SOLUTION Study of Sollpura™. View all press releases ». Jun 29, 2016 at 8:30 AM ET.
investor.anthera.com
Corporate Governance - Anthera
http://investor.anthera.com/corporate-governance.cfm
Phone: 1.510.856.5600. File is in Briefcase. File is in Briefcase. Nominating and Corporate Governance Committee Charter. File is in Briefcase. Code of Business Conduct and Ethics. File is in Briefcase. File is in Briefcase. Add file to Briefcase. Christopher S. Henney, PhD – Chairman. Dr Henney was previously a founder of Immunex Corp. and Icos Corp. Member of the Audit Committee. Member of the Nominating and Governance Committee. Paul F. Truex – Chief Executive Officer and Director. Prior to joining Ve...